Feasibility of FFR-CT and CCTA features to predict the hemodynamic changes of high take-off coronary artery

Jiong Ni; Shuihua Cheng; Peijun Wang; Chenjin Ge

doi:10.1101/2023.08.24.23294591

Abstract

Background High take-off coronary artery (HTCA) is a neglected coronary artery anomaly with debated clinical importance. Determining the pathophysiological significance of this anomaly remains challenging. The aim of this study was to explore clinical symptoms, anatomic features based on CCTA and FFR-CT which will help to predict significant hemodynamic change of HTCA.

Methods This retrospective study recruited 72 patients with HTCA undergoing CCTA and invasive coronary angiography. Demographic, clinical characteristics, anatomic and functional features based on CCTA were collected to identified independent risk factors by multivariate logistical analysis. Receiver operating characteristic curve analysis was performed to determine the predictive accuracy of these factors.

Results Chest pain and the angle at the HTCA were identified as independent risk factors (p=0.005, p=0.002) associated hemodynamical significant HTCA. The value of FFR-CT was consistency with FFR in HTCA patients (VIF=73.811). The index of FFR-CT had significantly larger AUC than the index of chest pain (p=0.003) and similar AUC with the angel at the HTCA (p=0.059). Compared with combined index of angle at HTCA plus chest pain, FFR-CT had a larger AUC (p=0.000). The similar AUC was found between FFR-CT and the combined index of chest pain, angle at the HTCA plus FFR-CT (p=0.2359).

Conclusions FFR-CT, chest pain and angel at HTCA based on CCTA played a great role to predict significant hemodynamic changes of HTCA. FFR-CT had a superior diagnostic performance to predict abnormal hemodynamic changes in patients with HTCA.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

This retrospective anonymous study was approved by the Ethics Committee and the Ethics Committee waived the need for informed consent.

Funding Statement

none

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

the Institutional Review Board of Shanghai Hospital of Traditional Chinese Medicine and Shanghai Tongji Hospital

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes